Skip to Content

Ebos Group Ltd EBO

Morningstar Rating
NZD 34.90 −0.10 (0.29%)
View Full Chart
Unlock our analysis with Morningstar Investor

Price vs Fair Value

EBO is trading at a 15% premium.
Price
NZD 35.00
Fair Value
NZD 72.50
Uncertainty
Medium
1-Star Price
NZD 89.96
5-Star Price
NZD 38.17
Economic Moat
Nvtpsb
Capital Allocation
Zlqpjggrj
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EBO is a good fit for your portfolio.

Trading Information

Previous Close Price
NZD 35.00
Day Range
NZD 34.9035.06
52-Week Range
NZD 33.5045.29
Bid/Ask
NZD 34.90 / NZD 34.98
Market Cap
NZD 6.69 Bil
Volume/Avg
21,118 / 207,217

Key Statistics

Price/Earnings (Normalized)
23.62
Price/Sales
0.49
Dividend Yield (Trailing)
3.26%
Dividend Yield (Forward)
3.26%
Total Yield
3.25%

Company Profile

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
5,000

Competitors

Valuation

Metric
EBO
COR
CAH
Price/Earnings (Normalized)
23.6219.0315.06
Price/Book Value
2.6452.30
Price/Sales
0.490.180.12
Price/Cash Flow
18.2714.9310.74
Price/Earnings
EBO
COR
CAH

Financial Strength

Metric
EBO
COR
CAH
Quick Ratio
0.710.480.43
Current Ratio
1.240.880.98
Interest Coverage
5.059.4118.37
Quick Ratio
EBO
COR
CAH

Profitability

Metric
EBO
COR
CAH
Return on Assets (Normalized)
4.19%4.19%3.89%
Return on Equity (Normalized)
11.55%574.41%
Return on Invested Capital (Normalized)
8.77%48.08%89.85%
Return on Assets
EBO
COR
CAH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpKsmfrwtdTvhkh$70.6 Bil
COR
Cencora IncVfyypdrDqkqgd$47.6 Bil
CAH
Cardinal Health IncTjjttvdVnmphk$24.9 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HGgkflbf$8.2 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HNblrnz$8.2 Bil
SHTDF
Sinopharm Group Co LtdHggpsxz$7.9 Bil
SHTDY
Sinopharm Group Co Ltd ADRBkvptq$7.9 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoMpmqpd$7.6 Bil
MEPDF
Medipal Holdings CorpFmbk$3.3 Bil
MAHLY
Medipal Holdings Corp ADRJsgz$3.3 Bil

Sponsor Center